Reduced acquisition time PET pharmacokinetic modelling using simultaneous ASL–MRI: proof of concept

Author:

Scott Catherine J1ORCID,Jiao Jieqing1,Melbourne Andrew1,Burgos Ninon12,Cash David M13,De Vita Enrico456,Markiewicz Pawel J1,O'Connor Antoinette3,Thomas David L147,Weston Philip SJ3,Schott Jonathan M3,Hutton Brian F89,Ourselin Sébastien10

Affiliation:

1. Translational Imaging Group, CMIC, University College London, London, UK

2. Inria, Aramis project-team, Institut du Cerveau et de la Moelle épinière, Inserm, CNRS, Sorbonne Université, Paris, France

3. Dementia Research Centre, Institute of Neurology, University College London, London, UK

4. Neuroradiological Academic Unit, UCL Institute of Neurology, London, UK

5. Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, UCL Hospitals Foundation Trust, London, UK

6. Department of Biomedical Engineering, School of Biomedical Engineering & Imaging Sciences, King's College London, King's Health Partners, St Thomas' Hospital, London, UK

7. Leonard Wolfson Experimental Neurology Centre, UCL Institute of Neurology London, UK

8. Institute of Nuclear Medicine, University College London, London, UK

9. Centre for Medical Radiation Physics, University of Wollongong, NSW, Australia

10. School of Biomedical Engineering & Imaging Sciences, King's College London, London, UK

Abstract

Pharmacokinetic modelling on dynamic positron emission tomography (PET) data is a quantitative technique. However, the long acquisition time is prohibitive for routine clinical use. Instead, the semi-quantitative standardised uptake value ratio (SUVR) from a shorter static acquisition is used, despite its sensitivity to blood flow confounding longitudinal analysis. A method has been proposed to reduce the dynamic acquisition time for quantification by incorporating cerebral blood flow (CBF) information from arterial spin labelling (ASL) magnetic resonance imaging (MRI) into the pharmacokinetic modelling. In this work, we optimise and validate this framework for a study of ageing and preclinical Alzheimer's disease. This methodology adapts the simplified reference tissue model (SRTM) for a reduced acquisition time (RT-SRTM) and is applied to [18F]-florbetapir PET data for amyloid-β quantification. Evaluation shows that the optimised RT-SRTM can achieve amyloid burden estimation from a 30-min PET/MR acquisition which is comparable with the gold standard SRTM applied to 60 min of PET data. Conversely, SUVR showed a significantly higher error and bias, and a statistically significant correlation with tracer delivery due to the influence of blood flow. The optimised RT-SRTM produced amyloid burden estimates which were uncorrelated with tracer delivery indicating its suitability for longitudinal studies.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,Neurology (clinical),Neurology

Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3